Table of Content

1 RNA Vaccines Introduction and Market Overview

• 1.1 Objectives of the Study
• 1.2 Overview of RNA Vaccines
• 1.3 Scope of The Study
  • 1.3.1 Key Market Segments
  • 1.3.2 Players Covered
  • 1.3.3 COVID-19's impact on the RNA Vaccines industry
• 1.4 Methodology of The Study
• 1.5 Research Data Source

2 Executive Summary

• 2.1 Market Overview
  • 2.1.1 Global RNA Vaccines Market Size, 2015 – 2020
  • 2.1.2 Global RNA Vaccines Market Size by Type, 2015 – 2020
  • 2.1.3 Global RNA Vaccines Market Size by Application, 2015 – 2020
  • 2.1.4 Global RNA Vaccines Market Size by Region, 2015 - 2025
• 2.2 Business Environment Analysis
  • 2.2.1 Global COVID-19 Status and Economic Overview
  • 2.2.2 Influence of COVID-19 Outbreak on RNA Vaccines Industry Development

3 Industry Chain Analysis

• 3.1 Upstream Raw Material Suppliers of RNA Vaccines Analysis
• 3.2 Major Players of RNA Vaccines
• 3.3 RNA Vaccines Manufacturing Cost Structure Analysis
  • 3.3.1 Production Process Analysis
  • 3.3.2 Manufacturing Cost Structure of RNA Vaccines
  • 3.3.3 Labor Cost of RNA Vaccines
• 3.4 Market Distributors of RNA Vaccines
• 3.5 Major Downstream Buyers of RNA Vaccines Analysis
• 3.6 The Impact of Covid-19 From the Perspective of Industry Chain
• 3.7 Regional Import and Export Controls Will Exist for a Long Time
• 3.8 Continued downward PMI Spreads Globally

4 Global RNA Vaccines Market, by Type

• 4.1 Global RNA Vaccines Value and Market Share by Type (2015-2020)
• 4.2 Global RNA Vaccines Production and Market Share by Type (2015-2020)
• 4.3 Global RNA Vaccines Value and Growth Rate by Type (2015-2020)
  • 4.3.1 Global RNA Vaccines Value and Growth Rate of Individualized Cancer Treatment MRNA Vaccine
  • 4.3.2 Global RNA Vaccines Value and Growth Rate of Infectious Disease Treatment MRNA Vaccine
  • 4.3.3 Global RNA Vaccines Value and Growth Rate of Infection Prevention MRNA Vaccine
• 4.4 Global RNA Vaccines Price Analysis by Type (2015-2020)

5 RNA Vaccines Market, by Application

• 5.1 Downstream Market Overview
• 5.2 Global RNA Vaccines Consumption and Market Share by Application (2015-2020)
• 5.3 Global RNA Vaccines Consumption and Growth Rate by Application (2015-2020)
  • 5.3.1 Global RNA Vaccines Consumption and Growth Rate of Infectious Disease (2015-2020)
  • 5.3.2 Global RNA Vaccines Consumption and Growth Rate of Cancer (2015-2020)
  • 5.3.3 Global RNA Vaccines Consumption and Growth Rate of Other (2015-2020)

6 Global RNA Vaccines Market Analysis by Regions

• 6.1 Global RNA Vaccines Sales, Revenue and Market Share by Regions
  • 6.1.1 Global RNA Vaccines Sales by Regions (2015-2020)
  • 6.1.2 Global RNA Vaccines Revenue by Regions (2015-2020)
• 6.2 North America RNA Vaccines Sales and Growth Rate (2015-2020)
• 6.3 Europe RNA Vaccines Sales and Growth Rate (2015-2020)
• 6.4 Asia-Pacific RNA Vaccines Sales and Growth Rate (2015-2020)
• 6.5 Middle East and Africa RNA Vaccines Sales and Growth Rate (2015-2020)
• 6.6 South America RNA Vaccines Sales and Growth Rate (2015-2020)

7 North America RNA Vaccines Market Analysis by Countries

• 7.1 The Influence of COVID-19 on North America Market
• 7.2 North America RNA Vaccines Sales, Revenue and Market Share by Countries
  • 7.2.1 North America RNA Vaccines Sales by Countries (2015-2020)
  • 7.2.2 North America RNA Vaccines Revenue by Countries (2015-2020)
• 7.3 United States RNA Vaccines Sales and Growth Rate (2015-2020)
• 7.4 Canada RNA Vaccines Sales and Growth Rate (2015-2020)
• 7.5 Mexico RNA Vaccines Sales and Growth Rate (2015-2020)

8 Europe RNA Vaccines Market Analysis by Countries

• 8.1 The Influence of COVID-19 on Europe Market
• 8.2 Europe RNA Vaccines Sales, Revenue and Market Share by Countries
  • 8.2.1 Europe RNA Vaccines Sales by Countries (2015-2020)
  • 8.2.2 Europe RNA Vaccines Revenue by Countries (2015-2020)
• 8.3 Germany RNA Vaccines Sales and Growth Rate (2015-2020)
• 8.4 UK RNA Vaccines Sales and Growth Rate (2015-2020)
• 8.5 France RNA Vaccines Sales and Growth Rate (2015-2020)
• 8.6 Italy RNA Vaccines Sales and Growth Rate (2015-2020)
• 8.7 Spain RNA Vaccines Sales and Growth Rate (2015-2020)
• 8.8 Russia RNA Vaccines Sales and Growth Rate (2015-2020)

9 Asia Pacific RNA Vaccines Market Analysis by Countries

• 9.1 The Influence of COVID-19 on Asia Pacific Market
• 9.2 Asia Pacific RNA Vaccines Sales, Revenue and Market Share by Countries
  • 9.2.1 Asia Pacific RNA Vaccines Sales by Countries (2015-2020)
  • 9.2.2 Asia Pacific RNA Vaccines Revenue by Countries (2015-2020)
• 9.3 China RNA Vaccines Sales and Growth Rate (2015-2020)
• 9.4 Japan RNA Vaccines Sales and Growth Rate (2015-2020)
• 9.5 South Korea RNA Vaccines Sales and Growth Rate (2015-2020)
• 9.6 India RNA Vaccines Sales and Growth Rate (2015-2020)
• 9.7 Southeast Asia RNA Vaccines Sales and Growth Rate (2015-2020)
• 9.8 Australia RNA Vaccines Sales and Growth Rate (2015-2020)

10 Middle East and Africa RNA Vaccines Market Analysis by Countries

• 10.1 The Influence of COVID-19 on Middle East and Africa Market
• 10.2 Middle East and Africa RNA Vaccines Sales, Revenue and Market Share by Countries
  • 10.2.1 Middle East and Africa RNA Vaccines Sales by Countries (2015-2020)
  • 10.2.2 Middle East and Africa RNA Vaccines Revenue by Countries (2015-2020)
• 10.3 Saudi Arabia RNA Vaccines Sales and Growth Rate (2015-2020)
• 10.4 UAE RNA Vaccines Sales and Growth Rate (2015-2020)
• 10.5 Egypt RNA Vaccines Sales and Growth Rate (2015-2020)
• 10.6 Nigeria RNA Vaccines Sales and Growth Rate (2015-2020)
• 10.7 South Africa RNA Vaccines Sales and Growth Rate (2015-2020)

11 South America RNA Vaccines Market Analysis by Countries

• 11.1 The Influence of COVID-19 on Middle East and Africa Market
• 11.2 South America RNA Vaccines Sales, Revenue and Market Share by Countries
  • 11.2.1 South America RNA Vaccines Sales by Countries (2015-2020)
  • 11.2.2 South America RNA Vaccines Revenue by Countries (2015-2020)
• 11.3 Brazil RNA Vaccines Sales and Growth Rate (2015-2020)
• 11.4 Argentina RNA Vaccines Sales and Growth Rate (2015-2020)
• 11.5 Columbia RNA Vaccines Sales and Growth Rate (2015-2020)
• 11.6 Chile RNA Vaccines Sales and Growth Rate (2015-2020)

12 Competitive Landscape

• 12.1 Ethris
  • 12.1.1 Ethris Basic Information
  • 12.1.2 RNA Vaccines Product Introduction
  • 12.1.3 Ethris Production, Value, Price, Gross Margin 2015-2020
• 12.2 eTheRNA
  • 12.2.1 eTheRNA Basic Information
  • 12.2.2 RNA Vaccines Product Introduction
  • 12.2.3 eTheRNA Production, Value, Price, Gross Margin 2015-2020
• 12.3 In-Cell-Art
  • 12.3.1 In-Cell-Art Basic Information
  • 12.3.2 RNA Vaccines Product Introduction
  • 12.3.3 In-Cell-Art Production, Value, Price, Gross Margin 2015-2020
• 12.4 Sangamo Therapeutics
  • 12.4.1 Sangamo Therapeutics Basic Information
  • 12.4.2 RNA Vaccines Product Introduction
  • 12.4.3 Sangamo Therapeutics Production, Value, Price, Gross Margin 2015-2020
• 12.5 CureVac
  • 12.5.1 CureVac Basic Information
  • 12.5.2 RNA Vaccines Product Introduction
  • 12.5.3 CureVac Production, Value, Price, Gross Margin 2015-2020
• 12.6 Moderna Therapeutics
  • 12.6.1 Moderna Therapeutics Basic Information
  • 12.6.2 RNA Vaccines Product Introduction
  • 12.6.3 Moderna Therapeutics Production, Value, Price, Gross Margin 2015-2020
• 12.7 Translate Bio
  • 12.7.1 Translate Bio Basic Information
  • 12.7.2 RNA Vaccines Product Introduction
  • 12.7.3 Translate Bio Production, Value, Price, Gross Margin 2015-2020
• 12.8 Tiba Biotechnology
  • 12.8.1 Tiba Biotechnology Basic Information
  • 12.8.2 RNA Vaccines Product Introduction
  • 12.8.3 Tiba Biotechnology Production, Value, Price, Gross Margin 2015-2020
• 12.9 Argos Therapeutics
  • 12.9.1 Argos Therapeutics Basic Information
  • 12.9.2 RNA Vaccines Product Introduction
  • 12.9.3 Argos Therapeutics Production, Value, Price, Gross Margin 2015-2020
• 12.10 BioNTech
  • 12.10.1 BioNTech Basic Information
  • 12.10.2 RNA Vaccines Product Introduction
  • 12.10.3 BioNTech Production, Value, Price, Gross Margin 2015-2020

13 Industry Outlook

• 13.1 Market Driver Analysis
  • 13.1.2 Market Restraints Analysis
  • 13.1.3 Market Trends Analysis
• 13.2 Merger, Acquisition and New Investment
• 13.3 News of Product Release

14 Global RNA Vaccines Market Forecast

• 14.1 Global RNA Vaccines Market Value & Volume Forecast, by Type (2020-2025)
  • 14.1.1 Individualized Cancer Treatment MRNA Vaccine Market Value and Volume Forecast (2020-2025)
  • 14.1.2 Infectious Disease Treatment MRNA Vaccine Market Value and Volume Forecast (2020-2025)
  • 14.1.3 Infection Prevention MRNA Vaccine Market Value and Volume Forecast (2020-2025)
• 14.2 Global RNA Vaccines Market Value & Volume Forecast, by Application (2020-2025)
  • 14.2.1 Infectious Disease Market Value and Volume Forecast (2020-2025)
  • 14.2.2 Cancer Market Value and Volume Forecast (2020-2025)
  • 14.2.3 Other Market Value and Volume Forecast (2020-2025)
• 14.3 RNA Vaccines Market Analysis and Forecast by Region
  • 14.3.1 North America Market Value and Consumption Forecast (2020-2025)
  • 14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
  • 14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
  • 14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
  • 14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 New Project Feasibility Analysis

• 15.1 Industry Barriers and New Entrants SWOT Analysis
  • 15.1.1 Porter’s Five Forces Analysis
  • 15.1.2 New Entrants SWOT Analysis
• 15.2 Analysis and Suggestions on New Project Investment

List of Tables and Figures

Figure Product Picture of RNA Vaccines

Table Product Specification of RNA Vaccines

Table RNA Vaccines Key Market Segments

Table Key Players RNA Vaccines Covered

Figure Global RNA Vaccines Market Size, 2015 – 2025

Table Different Types of RNA Vaccines

Figure Global RNA Vaccines Value ($) Segment by Type from 2015-2020

Figure Global RNA Vaccines Market Share by Types in 2019

Table Different Applications of RNA Vaccines

Figure Global RNA Vaccines Value ($) Segment by Applications from 2015-2020

Figure Global RNA Vaccines Market Share by Applications in 2019

Figure Global RNA Vaccines Market Share by Regions in 2019

Figure North America RNA Vaccines Production Value ($) and Growth Rate (2015-2020)

Figure Europe RNA Vaccines Production Value ($) and Growth Rate (2015-2020)

Figure Asia Pacific RNA Vaccines Production Value ($) and Growth Rate (2015-2020)

Figure Middle East and Africa RNA Vaccines Production Value ($) and Growth Rate (2015-2020)

Figure South America RNA Vaccines Production Value ($) and Growth Rate (2015-2020)

Table Global COVID-19 Status and Economic Overview

Figure Global COVID-19 Status

Figure COVID-19 Comparison of Major Countries

Figure Industry Chain Analysis of RNA Vaccines

Table Upstream Raw Material Suppliers of RNA Vaccines with Contact Information

Table Major Players Headquarters, and Service Area of RNA Vaccines

Figure Major Players Production Value Market Share of RNA Vaccines in 2019

Table Major Players RNA Vaccines Product Types in 2019

Figure Production Process of RNA Vaccines

Figure Manufacturing Cost Structure of RNA Vaccines

Figure Channel Status of RNA Vaccines

Table Major Distributors of RNA Vaccines with Contact Information

Table Major Downstream Buyers of RNA Vaccines with Contact Information

Table Global RNA Vaccines Value ($) by Type (2015-2020)

Table Global RNA Vaccines Value Share by Type (2015-2020)

Figure Global RNA Vaccines Value Share by Type (2015-2020)

Table Global RNA Vaccines Production by Type (2015-2020)

Table Global RNA Vaccines Production Share by Type (2015-2020)

Figure Global RNA Vaccines Production Share by Type (2015-2020)

Figure Global RNA Vaccines Value ($) and Growth Rate of Individualized Cancer Treatment MRNA Vaccine (2015-2020)

Figure Global RNA Vaccines Value ($) and Growth Rate of Infectious Disease Treatment MRNA Vaccine (2015-2020)

Figure Global RNA Vaccines Value ($) and Growth Rate of Infection Prevention MRNA Vaccine (2015-2020)

Figure Global RNA Vaccines Price by Type (2015-2020)

Figure Downstream Market Overview

Table Global RNA Vaccines Consumption by Application (2015-2020)

Table Global RNA Vaccines Consumption Market Share by Application (2015-2020)

Figure Global RNA Vaccines Consumption Market Share by Application (2015-2020)

Figure Global RNA Vaccines Consumption and Growth Rate of Infectious Disease (2015-2020)

Figure Global RNA Vaccines Consumption and Growth Rate of Cancer (2015-2020)

Figure Global RNA Vaccines Consumption and Growth Rate of Other (2015-2020)

Figure Global RNA Vaccines Sales and Growth Rate (2015-2020)

Figure Global RNA Vaccines Revenue (M USD) and Growth (2015-2020)

Table Global RNA Vaccines Sales by Regions (2015-2020)

Table Global RNA Vaccines Sales Market Share by Regions (2015-2020)

Table Global RNA Vaccines Revenue (M USD) by Regions (2015-2020)

Table Global RNA Vaccines Revenue Market Share by Regions (2015-2020)

Table Global RNA Vaccines Revenue Market Share by Regions in 2015

Table Global RNA Vaccines Revenue Market Share by Regions in 2019

Figure North America RNA Vaccines Sales and Growth Rate (2015-2020)

Figure Europe RNA Vaccines Sales and Growth Rate (2015-2020)

Figure Asia-Pacific RNA Vaccines Sales and Growth Rate (2015-2020)

Figure Middle East and Africa RNA Vaccines Sales and Growth Rate (2015-2020)

Figure South America RNA Vaccines Sales and Growth Rate (2015-2020)

Figure North America COVID-19 Status

Figure North America COVID-19 Confirmed Cases Major Distribution

Figure North America RNA Vaccines Revenue (M USD) and Growth (2015-2020)

Table North America RNA Vaccines Sales by Countries (2015-2020)

Table North America RNA Vaccines Sales Market Share by Countries (2015-2020)

Table North America RNA Vaccines Revenue (M USD) by Countries (2015-2020)

Table North America RNA Vaccines Revenue Market Share by Countries (2015-2020)

Figure United States RNA Vaccines Sales and Growth Rate (2015-2020)

Figure Canada RNA Vaccines Sales and Growth Rate (2015-2020)

Figure Mexico RNA Vaccines Sales and Growth (2015-2020)

Figure Europe COVID-19 Status

Figure Europe COVID-19 Confirmed Cases Major Distribution

Figure Europe RNA Vaccines Revenue (M USD) and Growth (2015-2020)

Table Europe RNA Vaccines Sales by Countries (2015-2020)

Table Europe RNA Vaccines Sales Market Share by Countries (2015-2020)

Table Europe RNA Vaccines Revenue (M USD) by Countries (2015-2020)

Table Europe RNA Vaccines Revenue Market Share by Countries (2015-2020)

Figure Germany RNA Vaccines Sales and Growth Rate (2015-2020)

Figure UK RNA Vaccines Sales and Growth Rate (2015-2020)

Figure France RNA Vaccines Sales and Growth (2015-2020)

Figure Italy RNA Vaccines Sales and Growth (2015-2020)

Figure Spain RNA Vaccines Sales and Growth (2015-2020)

Figure Russia RNA Vaccines Sales and Growth (2015-2020)

Figure Asia Pacific COVID-19 Status

Figure Asia Pacific RNA Vaccines Revenue (M USD) and Growth (2015-2020)

Table Asia Pacific RNA Vaccines Sales by Countries (2015-2020)

Table Asia Pacific RNA Vaccines Sales Market Share by Countries (2015-2020)

Table Asia Pacific RNA Vaccines Revenue (M USD) by Countries (2015-2020)

Table Asia Pacific RNA Vaccines Revenue Market Share by Countries (2015-2020)

Figure China RNA Vaccines Sales and Growth Rate (2015-2020)

Figure Japan RNA Vaccines Sales and Growth Rate (2015-2020)

Figure South Korea RNA Vaccines Sales and Growth (2015-2020)

Figure India RNA Vaccines Sales and Growth (2015-2020)

Figure Southeast Asia RNA Vaccines Sales and Growth (2015-2020)

Figure Australia RNA Vaccines Sales and Growth (2015-2020)

Figure Middle East RNA Vaccines Revenue (M USD) and Growth (2015-2020)

Table Middle East RNA Vaccines Sales by Countries (2015-2020)

Table Middle East and Africa RNA Vaccines Sales Market Share by Countries (2015-2020)

Table Middle East and Africa RNA Vaccines Revenue (M USD) by Countries (2015-2020)

Table Middle East and Africa RNA Vaccines Revenue Market Share by Countries (2015-2020)

Figure Saudi Arabia RNA Vaccines Sales and Growth Rate (2015-2020)

Figure UAE RNA Vaccines Sales and Growth Rate (2015-2020)

Figure Egypt RNA Vaccines Sales and Growth (2015-2020)

Figure Nigeria RNA Vaccines Sales and Growth (2015-2020)

Figure South Africa RNA Vaccines Sales and Growth (2015-2020)

Figure South America RNA Vaccines Revenue (M USD) and Growth (2015-2020)

Table South America RNA Vaccines Sales by Countries (2015-2020)

Table South America RNA Vaccines Sales Market Share by Countries (2015-2020)

Table South America RNA Vaccines Revenue (M USD) by Countries (2015-2020)

Table South America RNA Vaccines Revenue Market Share by Countries (2015-2020)

Figure Brazil RNA Vaccines Sales and Growth Rate (2015-2020)

Figure Argentina RNA Vaccines Sales and Growth Rate (2015-2020)

Figure Columbia RNA Vaccines Sales and Growth (2015-2020)

Figure Chile RNA Vaccines Sales and Growth (2015-2020)

Figure Top 3 Market Share of RNA Vaccines Companies in 2019

Figure Top 6 Market Share of RNA Vaccines Companies in 2019

Table Major Players Production Value ($) Share (2015-2020)

Table Ethris Profile

Table Ethris Product Introduction

Figure Ethris Production and Growth Rate

Figure Ethris Value ($) Market Share 2015-2020

Table eTheRNA Profile

Table eTheRNA Product Introduction

Figure eTheRNA Production and Growth Rate

Figure eTheRNA Value ($) Market Share 2015-2020

Table In-Cell-Art Profile

Table In-Cell-Art Product Introduction

Figure In-Cell-Art Production and Growth Rate

Figure In-Cell-Art Value ($) Market Share 2015-2020

Table Sangamo Therapeutics Profile

Table Sangamo Therapeutics Product Introduction

Figure Sangamo Therapeutics Production and Growth Rate

Figure Sangamo Therapeutics Value ($) Market Share 2015-2020

Table CureVac Profile

Table CureVac Product Introduction

Figure CureVac Production and Growth Rate

Figure CureVac Value ($) Market Share 2015-2020

Table Moderna Therapeutics Profile

Table Moderna Therapeutics Product Introduction

Figure Moderna Therapeutics Production and Growth Rate

Figure Moderna Therapeutics Value ($) Market Share 2015-2020

Table Translate Bio Profile

Table Translate Bio Product Introduction

Figure Translate Bio Production and Growth Rate

Figure Translate Bio Value ($) Market Share 2015-2020

Table Tiba Biotechnology Profile

Table Tiba Biotechnology Product Introduction

Figure Tiba Biotechnology Production and Growth Rate

Figure Tiba Biotechnology Value ($) Market Share 2015-2020

Table Argos Therapeutics Profile

Table Argos Therapeutics Product Introduction

Figure Argos Therapeutics Production and Growth Rate

Figure Argos Therapeutics Value ($) Market Share 2015-2020

Table BioNTech Profile

Table BioNTech Product Introduction

Figure BioNTech Production and Growth Rate

Figure BioNTech Value ($) Market Share 2015-2020

Table Market Driving Factors of RNA Vaccines

Table Merger, Acquisition and New Investment

Table Global RNA Vaccines Market Value ($) Forecast, by Type

Table Global RNA Vaccines Market Volume Forecast, by Type

Figure Global RNA Vaccines Market Value ($) and Growth Rate Forecast of Individualized Cancer Treatment MRNA Vaccine (2020-2025)

Figure Global RNA Vaccines Market Volume ($) and Growth Rate Forecast of Individualized Cancer Treatment MRNA Vaccine (2020-2025)

Figure Global RNA Vaccines Market Value ($) and Growth Rate Forecast of Infectious Disease Treatment MRNA Vaccine (2020-2025)

Figure Global RNA Vaccines Market Volume ($) and Growth Rate Forecast of Infectious Disease Treatment MRNA Vaccine (2020-2025)

Figure Global RNA Vaccines Market Value ($) and Growth Rate Forecast of Infection Prevention MRNA Vaccine (2020-2025)

Figure Global RNA Vaccines Market Volume ($) and Growth Rate Forecast of Infection Prevention MRNA Vaccine (2020-2025)

Table Global Market Value ($) Forecast by Application (2020-2025)

Table Global Market Volume Forecast by Application (2020-2025)

Figure Market Value ($) and Growth Rate Forecast of Infectious Disease (2020-2025)

Figure Market Volume and Growth Rate Forecast of Infectious Disease (2020-2025)

Figure Market Value ($) and Growth Rate Forecast of Cancer (2020-2025)

Figure Market Volume and Growth Rate Forecast of Cancer (2020-2025)

Figure Market Value ($) and Growth Rate Forecast of Other (2020-2025)

Figure Market Volume and Growth Rate Forecast of Other (2020-2025)

Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)

Figure North America Consumption and Growth Rate Forecast (2020-2025)

Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)

Figure Europe Consumption and Growth Rate Forecast (2020-2025)

Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)

Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)

Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)

Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)

Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)

Figure South America Consumption and Growth Rate Forecast (2020-2025)

Figure Porter’s Five Forces Analysis

Table New Entrants SWOT Analysis

Table New Project Analysis of Investment Recovery

RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of RNA has greatly favored the development of in vivo transfection strategies.
The RNA Vaccines market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the RNA Vaccines industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The RNA Vaccines market can be split based on product types, major applications, and important countries as follows:

Key players in the global RNA Vaccines market covered in Chapter 12:
Ethris
eTheRNA
In-Cell-Art
Sangamo Therapeutics
CureVac
Moderna Therapeutics
Translate Bio
Tiba Biotechnology
Argos Therapeutics
BioNTech

In Chapter 4 and 14.1, on the basis of types, the RNA Vaccines market from 2015 to 2025 is primarily split into:
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine

In Chapter 5 and 14.2, on the basis of applications, the RNA Vaccines market from 2015 to 2025 covers:
Infectious Disease
Cancer
Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025